Infectious Disease Fellowship

Infectious Disease Infographic

About the Program

The Infectious Disease Fellowship at the University of Iowa Hospitals and Clinics has the following aims:

  • To mentor trainees from diverse backgrounds to be outstanding ID clinicians, exemplary in their patient care
  • To train leaders of healthcare teams that optimize patient safety and healthcare quality
  • To train physician-scholars who expand medical and scientific knowledge through teaching, research, and publication

PDF iconIProgram Overview slide presenttion (pdf).

Judy Streit, MD, discusses the research experience for fellows

Benjamin Appenheimer, MD, discusses the clinical experience for fellows

Schedule

Clinical Requirements or Elective Options

  • Twelve months of clinical training (in- and outpatient rotations) divided between the University of Iowa Hospitals & Clinics (major component) and the Iowa City Veterans Affairs Medical Center (VA); Eight or nine of these twelve months are completed during the first year and include Transplant rotations
  • Two to Four weeks Clinical Microbiology rotation and twice weekly Micro tutorials
  • 1/2 day per 2 weeks Continuity of Care ID clinic at UI Hospitals & Clinics
  • 1/2 day per 2 weeks Continuity of Care HIV clinic at UI Hospitals & Clinics
  • Antimicrobial Stewardship/Hospital Epidemiology: 1 week each with additional elective time
  • Transplant ID (Solid Organ and Hem/BMT): 4 scheduled weeks during both year 1 and 2; additional elective time available
  • Travel clinics: four with option for additional clinics
  • Hepatology clinics: four to six
  • Electives available:  Orthopedics ID, Pediatrics ID, Allergy-Immunology, Dermatology, Addiction Medicine

Conferences/Meetings

Infectious Disease Grand Rounds (weekly): Two cases are presented by the fellows or staff as unknowns, discussed, and pertinent literature reviewed

 

  • Infectious Disease Grand Rounds (weekly): Two cases are presented by the fellows or staff as unknowns, discussed, and pertinent literature reviewed
  • Core Curriculum Conference (weekly): didactic lectures on general and specialty ID topics over 2 year cycle (See Curriculum for more details on topics)
  • Journal Club (monthly)
  • Research Conference (weekly): progress on ongoing ID related research activity is presented by faculty and fellows
  • Departmental Interdisciplinary Fellows' Curriculum (twice-monthly): presentations on common requirements of the Internal Medicine fellowship programs including ethics, coding and billing, statistics, sleep deprivation, practice management, etc. [view schedule]
  •  ID Week and second meeting of fellows' choice, such as SHEA meeting
  • University of Iowa Update in Infectious Disease Regional CME Meeting (annual)
  • Various multi-disciplinary conferences, including Morbidity/Mortality Conference for Internal Medicine, Internal Medicine Grand Rounds, etc.
  • ID Resident Curriculum Case-based Module facilitation (monthly): 2nd year fellows
  • Clinical Microbiology sessions twice per week with Team 1   

Clinical Activities

Clinical training usually is concentrated in the first year of the program.  Clinical assignments occur primarily at University of Iowa Hospitals & Clinics (UIHC). Some rotations occur at the Iowa City VA Health Care System which is located across the street.  Transplant ID and HIV Care are critical components of the fellow experience.

Clinical Rotations/Blocks

  • Team 1 General ID: Multidisciplinary UIHC inpatient consult service that includes residents and students on the team. This service typically performs 120-140 new consults per month.
  • Team 2 General ID: Outpatient consults.  The Team 2 rotation combines general ID clinic with an attending-directed inpatient consult service using an apprenticeship model of staffing
  • Clinical Microbiology: Intensive instruction and hands-on experience with the UIHC Clinical Microbiology Laboratory staff
  • Team 4/D: General ID consult for hospitalist services. Staffed 1:1 (apprenticeship model) with attending
  • Transplant ID
  • Antimicrobial Stewardship
  • Hospital Epidemiology
  • Hepatology Clinic
  • Travel Clinic
  • OPAT experience throughout clinical fellowship
  • Electives:   Allergy/Immunology, Pediatric Infectious Disease, Dermatology, Ortho ID, Addiction Medicine, NTM, Pulmonary Clinic

Curriculum

The Infectious Diseases Fellowship Program at the University of Iowa is ACGME accredited for two years, at the end of which the fellow will meet ABIM eligibility requirements.  

Clinical training is concentrated in the first year of the program.  Clinical rotations occur primarily at University of Iowa Hospitals & Clinics and with lesser activity at the Iowa City VA Medical Center, which is located across the street from UI Hospitals & Clinics.

Core Curriculum Topics

Clinical topics (partial list from the didactic curriculum)

  1. Important viral, fungal, mycobacterial, and select bacterial infections
  2. Organ System Infections of CNS/Cardiovascular, head & neck, respiratory, urogenital tract, etc.
  3. Infections in immunocompromised hosts, including solid organ transplant and hematopoietic cell transplant patients & people living with HIV
  4. Sexually transmitted infections
  5. Vector-borne illness
  6. Zoonoses
  7. Clinical Microbiology and Lab diagnostics
  8. Travel & Tropical Medicine/Parasitology
  9. Hospital Epidemiology, healthcare-associated infections
  10. Tuberculosis and nontuberculous mycobacterial infections
  11. Principles of prophylaxis: vaccination or immunotherapeutics
  12. Pharmacy and antimicrobial stewardship topics: including pharmacokinetic/pharmacodynamic principles for prescribing, antimicrobial resistance, etc.
  13. MSK Imaging
  14. Toxin-mediated syndromes
  15. Infections related to intravenous drug use; Addiction Medicine
  16. Health Equity in Infectious Diseases
  17. Study Design
  18. Quality Improvement
  19. IDSA AMS Curriculum

Clinical Experience

Fellows will develop expertise in the evaluation and management of patients with the following disorders, clinical situations and related needs:

  1. Full range of organ system infections (e.g., cardiovascular, CNS, bone and joints, etc.)
  2. Patients who are neutropenic due to malignancies and their treatments
  3. Patients with solid organ or hematopoietic cell transplantation
  4. Patients with HIV/AIDS or immunocompromised by other diseases or their treatments
  5. Infections of devices/hardware
  6. Sepsis, trauma and/or other critical illness (Medical, Surgical, Neurosurgical, Cardiovascular ICUs)
  7. Healthcare-associated infections
  8. Array of pathogen types (Viral, Fungal, Mycobacterial, Parasitic, Bacterial)
  9. Infections in pregnancy
  10. Fever of unknown origin
  11. Antibiotic optimization in both inpatient and outpatient settings
  12. Infection Prevention, including immunizations
  13. Sexually Transmitted Infections
  14. Infections of foreign-borne persons or acquired from overseas travel
  15. Adverse side effects of antimicrobials

Fellowship Tracks

Clinical/Clinician-Educator Track

Clinical/Clinician-Educator Track:  to prepare fellows for a career as an ID consultant and educator either in a private or academic setting:

  1. Elective rotations in addition to those of the standard curriculum include those listed as electives under “Clinical Activities”
  2. Antimicrobial Stewardship/Hospital Epidemiology electives, including participation in Infection Prevention Workgroup Meetings
  3. IDSA Membership and during the second year, attendance at IDWeek
  4. SHEA membership, if desired
  5. Nomination to participate in IDSA Clinical Fellows Meeting or other clinical meeting of fellows’ choice
  6. Participation in Department of Medicine Fellows as Clinician Educator Program (FACE), year 2, if desired
  7. Tropical medicine opportunity (Brazil, India, Thailand)
  8. Internal Medicine Resident ID curriculum teaching sessions, year 2
  9. Participation in UIHC Quality Leadership Academy

Healthcare Services and Healthcare Quality

This track prepares fellows for Infectious Disease careers with special emphasis in hospital epidemiology, health services research or healthcare quality, including antimicrobial stewardship.  It is anticipated that the majority of fellows who select this track are interested in an academic career.  Features of this track include the following (below). Components selected would depend on the professional goals of the individual trainee.

  1. IDSA Membership (all) and SHEA Membership
  2. Attendance at IDWeek, Year 2 (all)
  3. IDSA’s Antimicrobial Stewardship basic (all) and advanced curricula 
  4. Multiple months during year 2 (up to 6) participating in Antimicrobial Stewardship or Program of Hospital Epidemiology activities. The fellow would be expected to: a) embed within the AMS or Hospital Epi teams to develop knowledge and hands-on skills; b) contribute to the work of these teams or related committees; c) develop and implement quality improvement or scholarly projects mentored by faculty members from these areas. 
  5. Completion of the SHEA online fellows’ course: Health Care Epidemiology, Infection Control and Antimicrobial Stewardship (all)
  6. Attendance at the SHEA meeting with completion of the Training Certificate Course in Healthcare Epidemiology or Antibiotic Stewardship
  7. If an academic career is planned, paths to a Master’s of Public Health or Master’s of Science in Clinical Investigation during third and fourth research years are possible.  Usually these are combined with formal research fellowships (see below).  Coursework in statistics or epidemiology is possible for those not planning on a Master’s degree.
  8. Nomination to the VA Quality Scholars Program or the VA Health Services Research Fellowship (Two-year research/QI fellowship following clinical fellowship).  (Note that federal regulations from 2022 make it difficult for visa-holders to be VA research fellows through these programs.) 
  9. Participation in UIHC’s Quality Leadership Academy
  10. Mentored Computational Epidemiology scholarly projects leading to published manuscripts
  11. Development of ID physician surveys for the CDC’s Emerging Infections Network
  12. Participation in UIHC’s Quality Leadership Academy

Physician Investigator Track

Physician Investigator Track: to prepare fellows for careers in ID-related laboratory science or clinical investigation.

  1. Basic science emphasis
    1. Membership in specialty society related to research
    2. Support for 3rd and 4th years of research
      1. Parasitism Training Grant
      2. Immunology Training Grant
      3. T32 Training Grants at University of Iowa Carver College of Medicine (renewal due in 2025)
    3. Mentors/projects are available from within the ID division or from other divisions/departments (e.g., Microbiology, Immunology, Pulmonary Medicine, etc). Areas of focus within the ID division include:
      1. Inflammation and innate immunity [see faculty at Inflammation Program]
      2. Virology (Dr. Jack Stapleton , Dr. Jeff Meier, Dr. Sabrina Tan)
      3. Parasitology (Dr. Mary Wilson), including collaborative projects with Tropical Medicine Institute in Natal, Brazil (Selma Jeronimo, MD, PhD) and Banaras Hindu University (Varanasi, India)
      4. Vaccine Trials [see Vaccine Education and Research Unit]
      5. Other labs directed by Carver College of Medicine research faculty or University of Iowa departments
      6. Department of Microbiology and Immunology
    4. Scientific meeting during 2nd or 3rd year
  2. Clinical Investigation
    1. Mentored involvement in clinical trials (vaccine trials, HIV, anti-viral therapies) (See Major Areas of Scholarly Work section)

Rotation/Educational Experience: Year One

During the first year the fellow will receive in-depth education in clinical infectious diseases. About 2/3 of required clinical rotations occur in Year 1. Clinical rotations occur primarily at the University of Iowa Hospitals & Clinics. Some occur at the VA Medical Center (VAMC), which is located across the street from UI Hospitals & Clinics.  Rotations in Transplant ID, Antimicrobial Stewardship and Hospital Epidemiology are part of the curriculum. Fellows have weekly COC clinics (alternating between HIV and general ID) and may attend several Travel clinics when not on service.  The fellow will participate in ID Grand Rounds, core curriculum conferences, Journal Club, ID Faculty and Fellows’ conference and departmental fellows’ interdisciplinary conference.  During this first year, each fellow selects a faculty mentor(s) and scholarly project(s). The mentor will guide the fellows’ scholarly work and development during the second year and possibly third and fourth research years.

 

Team 1 - 1st Year

  • Inpatient UIHC Consults. On average, this service handles approximately 120-140 new consults per month. All consults are staffed with a faculty member
  • Approximately three months of the first year will be spent on Team 1 inpatient consult service
  • Medical Microbiology Rounds twice a week

Goals and Objectives

During this rotation, the first-year fellow is expected to:

  • Develop knowledge of infections commonly encountered in a variety of hosts and in variety of organ systems
  • Develop a logical approach to the differential diagnosis of various ID syndromes, recognize common clinical manifestations due to particular organisms or syndromes and develop a diagnostic and treatment plan that is effective and cost-conscious
  • Obtain a proficient, thorough history and perform a directed physical examination; write concise, meaningful consult notes.
  • Provide appropriate inpatient follow up and arrange for safe transitions of care
  • Effectively and appropriately supervise and teach rotating internal medicine residents and students
  • Develop effective communication skills with referring services and patients/caregivers
  • Perform a literature search for medical topics, and meaningfully interpret such literature in the context of a clinical case
  • Develop facility in providing parenteral or oral antimicrobials during hospitalization and after a patient’s discharge, and understand the financial and medical issues involved with extended antimicrobial administration
  • Acquire leadership skills in directing the consult team (which includes residents, students and pharmacy personnel)
  • Develop skills of an antimicrobial steward
  • Develop knowledge of methods to reduce the risk of healthcare associated infections and how/when to use vaccines or other prophylactic measures
  • Increase medical microbiology knowledge

Team 2 - 1st Year

  • Outpatient consults at University of Iowa Hospitals & Clinics, plus UI Hospitals & Clinics inpatient hospitalist consults with 1:1 fellow:staff model or VAMC inpatient consults
  • Two to three to four months of the first year will be assigned to Team 2 outpatient consult service (usually combined with VA inpatient consult service)

Goals and Objectives

During this rotation, the first year fellow is expected to:

  • Develop fund of knowledge for a wide variety infections encountered in the clinic, as well as in hospitalized patients
  • Develop a logical approach to differential diagnosis of various syndromes, develop a diagnostic and treatment plan that is appropriate and feasible
  • Provide effective patient follow up
  • Develop skills to communicate with the referring services or outside referral entities, both verbally and in writing
  • Perform a literature searches to address questions, and apply such literature into a clinical case
  • Prescribe parenteral and oral antimicrobials in outpatient and inpatient settings, and understand the medical and issues involved with extended antimicrobial administration
  • Apply principles of antimicrobial stewardship
  • Successfully oversee transitions of care and manage OPAT patients

Team 4/D - 1st Year

  • Inpatient UIHC Consults from non-teaching hospitalist services. On average, this service handles approximately 60 new consults per month. All consults are staffed 1:1 with a faculty member
  • Approximately 6 weeks of the first year will be spend on a dedicated Team 4/D inpatient consult service rotation.  There may be an additional few weeks on a combined Team 2 clinic/Team 4/D rotation.
  • A curriculum for the management of common inpatient ID scenarios will be rolled out in 2023-2024

Goals and Objectives

During this rotation, the first-year fellow:

  • Works in an apprenticeship model with the attending to deliver consultative ID care
  • Develops medical knowledge base of infections commonly encountered in diverse human hosts and affecting a variety of organ systems
  • Develops a logical approach to the differential diagnosis of various ID syndromes, recognize common clinical manifestations due to particular organisms or syndromes and develop a diagnostic and treatment plan that is effective and cost-conscious
  • Obtains a proficient, thorough history and performs a directed physical examination; writes concise, meaningful consult notes.
  • Provides appropriate inpatient follow up and arrange for safe transitions of care
  • Develops effective communication skills with referring services and patients/caregivers
  • Performs a literature search for medical topics, and interpret such literature in the context of a clinical case
  • Optimizes antibiotic prescribing for inpatients and after a patient’s discharge, and understand the financial and medical issues involved with extended antimicrobial administration
  • Develops other skills of an antimicrobial steward
  • Develops knowledge of methods to reduce the risk of healthcare associated infections and how/when to use vaccines or other prophylactic measures
  • Increases medical microbiology knowledge

Antimicrobial Stewardship

The goals of the year 1 rotation and year 2 elective are to give the fellows practical and scholarly training in Antimicrobial Stewardship

Trainees will participate in Antimicrobial Stewardship (AMS) at University of Iowa Hospitals & Clinics and the VA Hospital, joining the physician-pharmacy teams in their patient reviews and communication with teams. Didactic instruction strengthens AMS expertise gained.

Fellows will participate in the IDSA basic and advanced AMS curricula.

Clinical Microbiology

Two to four weeks will be spent in the clinical microbiology laboratory with intensive instruction and hands-on experience with a clinical microbiologist.  In addition, twice-weekly medical micro tutorials occur for Team 1 members; all fellows are invited.

Goals and Objectives

By the end of this rotation, the fellow is expected to:

  • Understand and recommend various methods of appropriately collecting and transporting various specimen
  • Be competent in microscopic examination of specimen
  • Understand various staining and culturing techniques for a variety of bacterial, mycobacterial, fungal, and viral pathogens, and the principles and appropriateness of molecular diagnostic techniques
  • Be able to interpret susceptibility data, and limitations of testing
  • Understand mechanisms of antimicrobial resistance

Teaching Methods

Daily plate rounds with the Clinical Microbiology Lab: Complete bench rotations on checklist. Work with pathology resident on service to organize Micro tutorials with the ID consult Team 1.

Microbiology lecture block, monthly Pathology Department micro conference.

Continuity of Care Clinic

Fellows see patients in follow-up who were previously seen by the inpatient consult service, as well as evaluate new outpatient ID consults in this every other week clinic.

Goals and Objectives:

  • Be familiar with management of outpatient IV antibiotics
  • Be familiar with the natural course of infections that require treatment for multiple weeks or resolve over lengthy periods of time
  • Recognize when the course of illness indicates possible complication of therapy or a suboptimal response that warrants further evaluation or change in therapy
  • Gain experience in outpatient evaluation and management of Infectious Diseases

Transplant Infectious Disease

Four weeks will be spent on the ID Transplant service during year 1.  Additional elective rotations are available.

Goals and Objectives

By the end of this rotation, the fellow is expected to:

  • Develop unique differential diagnoses and management plan tailored to this is immunocompromised population
  • Understand the net state of immunosuppression and how it predisposes to infections
  • Understand the principles of and indications for immuno-prophylaxis and chemo-prophylaxis in this population
  • Understand the drug interactions, toxicities, and mechanisms of action and input on the immune system of immunosuppressive agents
  • Perform an appropriate pre-transplant infectious diseases assessment
  • Demonstrate appropriate inpatient follow up care for this patient population
  • Communicate effectively with the referring transplant services, both verbally and in the medical record

Mix of Clinical Topics

There are on average about 25-30 inpatient and 6 outpatient consults per month.

Travel Clinic (limited number of assigned clinics)

  • Held twice weekly at University of Iowa Hospitals & Clinics, fellows rotate as per schedule
  • Each fellow will participate in 4 ½ day Travel clinics

Goals and Objectives

  • During this rotation, the fellow is expected to:
  • Become proficient in obtaining pertinent health history and vaccination history
  • Become proficient in predicting possible exposures based on patient’s itinerary, travel plans and underlying health status.
  • Become proficient in recommending immunoprophylaxis and chemoprophylaxis, in a manner individualized to the traveler’s medical and social needs and planned itinerary
  • Provide advice as to general principles of avoiding a variety of environmental exposures
  • Help arrange follow up if problems arise for returning travelers.
  • Develop understanding of, and comply with, various governmental requirements for travel

Teaching Methods

  • An ID attending or experienced advance practice provider is present for each patient encounter, reviews the relevant history and travel plans, and helps decide on the recommendations and counseling given to patients. Assessment, plans and encounter notes are reviewed.
  • Simulated patient tutorial available, overseen by Travel Clinic Director

Mix of Clinical Topics

There are usually 40-60 new travel clinic visits per month at UI Hospitals & Clinics. Patients traveling to countries all over the world are seen for pre-travel recommendations.

Patient Characteristics and types of clinical encounters, procedures and services:

  • Patients from a variety of socioeconomic levels and ancestral background are evaluated

Reading/Learning Lists

  • CDC Yellow Book
  • Travax Web site
  • Principles and Practice of Infectious Disease, Mandell, et. al., 7th edition
  • Core curriculum conferences on parasitology and tropical/travel medicine

Evaluation

Immediate feedback is given on each patient presentation. Written evaluations by the Travel clinic attendings are given biannually.

Virology COC Clinic

Over 600 patients are provided HIV care in the Virology Clinic, part of the Ryan White Program.  An integrated multidisciplinary model is used to manage the complex needs that may be encountered.  Fellows gain experience by managing a panel of patients whom they follow during their fellowship. 

Goals and Objectives:

  • Develop competence in the evaluation and management of patients with HIV infection, working within a multidisciplinary team
  • Gain competence in the prescribing of ARV for the treatment of HIV infection as well as treatment of HIV/Hepatitis C or HIV/Hepatitis B co-infections
  • Be familiar with risk factors for and manifestations, diagnosis, treatment and prevention of opportunistic infections
  • Provide preventive care for non-infectious co-morbidities associated with HIV infection

Hospital Epidemiology

The goals of the year 1 rotation and year 2 elective are to give the fellows practical and scholarly training in Hospital Epidemiology/Infection Control.

During the Hospital Epidemiology rotation, fellows will participate in multiple activities of the Program of Infection Prevention at UIHC.  The goal is to understand the principles of surveillance and experience a programmatic approach to infection prevention, quality improvement and outbreak investigation. We anticipate this experience will ignite ideas for scholarly work/Quality Improvement.

Fellows complete one of the following: a) SHEA online infection control course (Primer on Healthcare Epidemiology, Infection Control & Antimicrobial Stewardship); or b) SHEA spring or fall meeting in infection prevention

Rotation/Educational Experience: Year Two

Year 2 of fellowship provides considerable flexibility to engage in specialty training pertinent to the track chosen by the fellow (see discussion of tracks and schedule above for pertinent training opportunities).  This includes time to perform a scholarly project, overseen by a faculty mentor and assisted by other faculty.  Scholarly projects may be completed in areas of health services research, hospital epidemiology/infection prevention, quality improvement (including antimicrobial stewardship), clinical investigation, clinical microbiology, vaccine trials, clinical reviews or case series or in the basic sciences.  Approximately 4 months are spent on Teams 1, 2, 4/D, Transplant or specialty rotations.  Additional elective rotations are available.  The fellow will continue to participate in curriculum conferences, Journal Club, ID Grand Rounds, Clinical Microbiology rounds, ID Faculty and Fellows’ conference and fellows’ interdisciplinary conference. The SHEA online fellows’ curriculum is completed. There are clinical experiences for the management of viral hepatitis and travel medicine. Quality Improvement modules are completed.

 

Team 1 - 2nd Year

  • Inpatient University of Iowa Hospitals & Clinics Consults. On average, this service handles approximately 140 new consults per month
  • 1 to 2 months of the second year will be spent on Team 1 inpatient consult service

Goals and Objectives

During this rotation, the second year fellow is expected to:

  • Develop more advanced knowledge of infections commonly encountered in diverse human hosts and in variety of organ systems
  • Achieve greater autonomy in developing the differential diagnosis of various ID syndromes, recognize common clinical manifestations due to particular organisms or syndromes and develop a diagnostic and treatment plan that is effective and cost conscious
  • Obtain a proficient, thorough history and perform a directed physical examination; write concise, meaningful consult notes
  • Provide appropriate inpatient follow up, and arrange for safe transitions of care
  • Effectively and appropriately supervise and teach rotating internal medicine residents and students
  • Develop effective communication skills with referring services and patients/caregivers
  • Perform a literature search for medical topics, and meaningfully  interpret such literature in the context of a clinical case
  • Develop facility in providing parenteral or oral antimicrobials during hospitalization and after patient’s discharge, and understand the financial and medical issues involved with extended antimicrobial administration
  • Acquire advanced leadership skills in directing the consult team (which includes residents, students and pharmacy personnel)
  • Develop skills of an antimicrobial steward
  • Develop knowledge of methods to reduce the risk of healthcare associated infections and how/when to use vaccines or other prophylactic measures
  • Increase medical microbiology knowledge

Team 2 - 2nd Year

  • Outpatient consults at University of Iowa Hospitals & Clinics, limited UI Hospitals & Clinics inpatient consults and VAMC inpatient consults.
  • 1 or 2 months of the second year will be spent on Team 2 outpatient consult service.

Goals and Objectives

During this rotation, the second year fellow is expected to:

  • Increase independence
  • Develop medical knowledge base of wide variety  infections encountered in the clinic, as well as in hospitalized patients
  • Develop a logical approach to differential diagnosis of various syndromes, develop a diagnostic and treatment plan that is appropriate and feasible
  • Provide effective patient follow up
  • Develop skills to communicate with the referring services or outside referral entities, both verbally and in writing
  • Perform a literature searches to address questions, and apply such literature in to a clinical case
  • Prescribe parenteral and oral antimicrobials in outpatient and inpatient settings, and understand the medical and issues involved with extended antimicrobial administration
  • Apply principles of antimicrobial stewardship

Team 4/D - 2nd Year

  • Inpatient UIHC Consults from non-teaching hospitalist services. On average, this service handles approximately 60 new consults per month. All consults are staffed 1:1 with a faculty member
  • Four to six weeks of the second year will be spend on a dedicated Team 4/D inpatient consult service rotation.
  • A curriculum for the management of common inpatient clinical ID scenarios will be rolled out in 2023-2024

Goals and Objectives

During this rotation, the second-year fellow:

  • Works in an apprenticeship model with the attending to deliver consultative ID care
  • Develops more advanced medical knowledge base of infections affecting diverse human hosts and in a variety of organ systems
  • Develops a comprehensive approach to the differential diagnosis of various ID syndromes, recognize common clinical manifestations due to particular organisms or syndromes and develop a diagnostic and treatment plan that is effective and cost-conscious
  • Achieves greater autonomy in developing the differential diagnosis of various ID syndromes, recognize common clinical manifestations due to particular organisms or syndromes and develop a diagnostic and treatment plan that is effective and cost-conscious
  • Obtains a proficient, thorough history and perform a directed physical examination; write concise, meaningful consult notes.
  • Provides appropriate inpatient follow up and arrange for safe transitions of care
  • Develops effective communication skills with referring services and patients/caregivers
  • Performs a literature search for medical topics, and interpret such literature in the context of a clinical case
  • Optimizes antibiotic prescribing for inpatients and after a patient’s discharge, and understand the financial and medical issues involved with extended antimicrobial administration
  • Develops skills of an antimicrobial steward
  • Develops knowledge of methods to reduce the risk of healthcare associated infections and how/when to use vaccines or other prophylactic measures
  • Increases medical microbiology knowledge

Transplant ID - UIHC/VAMC Solid Organ Transplantation and Hematopoetic Cell Transplant Serivce

One rotation will be spent on the ID Transplant service during year 2.  Additional elective rotations are available.

Goals and Objectives

By the end of this rotation, the fellow is expected to:

  • Develop a differential diagnosis and management plan for patients in this immunocompromised population
  • Understand the net state of immunosuppression and its impact on patient predisposition to infectious complications over time
  • Understand the principles of and indications for immuno-prophylaxis and chemo-prophylaxis in this population
  • Understand the drug interactions, toxicities, and mechanisms of action of immunosuppressive agents
  • Perform an appropriate pre-transplant infectious diseases assessment
  • Demonstrate appropriate inpatient follow up care for this patient population
  • Communicate effectively with the transplant service, both verbally and in the medical record
  • Recognize common infection entities of the vulnerable patient and how they vary with time after treatment

Mix of Clinical Topics

There are on average about 25-30 inpatient and 6 outpatient consults per month.

Antimicrobial Stewardship

The goals of the year 1 rotation and year 2 elective are to give the fellows practical and scholarly training in Antimicrobial Stewardship

Trainees will participate in Antimicrobial Stewardship (AMS) at University of Iowa Hospitals & Clinics and the VA Hospital, joining the physician-pharmacy teams in their patient reviews and communication with teams. Didactic instruction strengthens AMS expertise gained.

Fellows will participate in the IDSA basic and advanced AMS curricula.

 

General ID Continuity of Care Clinic

Fellows see patients in follow-up who were previously seen by the inpatient consult service, as well as evaluate new outpatient ID consults in this every other week clinic.

Goals and Objectives:

Be familiar with management of outpatient IV antibiotics
Be familiar with the natural course of infections that require treatment for multiple weeks or resolve over lengthy periods of time
Recognize when the course of illness indicates possible complication of therapy or a suboptimal response that warrants further evaluation or change in therapy
Gain experience in outpatient evaluation and management of Infectious Diseases

Hepatology Clinic (limited number of assigned clinics)

Each fellow will have 5 to 6 half-day clinics during the second year of training.

Goals and Objectives

By the end of this rotation, the fellow is expected to:

Establish an appropriate and logical work up of viral hepatitis
Understand risks and benefits of obtaining a liver biopsy
Understand the principles of and indications for anti-viral therapy in this patient population
Understand the drug interactions, toxicities, and mechanisms of action of anti-viral agents used for treatment of viral hepatitis
Demonstrate appropriate inpatient and outpatient follow up care for this patient population
Communicate effectively with the referring services, both verbally and in the medical record

Teaching Methods

A hepatology attending is present for each patient encounter, reviews the relevant history and treatment plans. Assessment, plans and encounter notes are reviewed.

Orthopedic Infectious Disease

Elective rotations will be available on the ID ortho service. 

Goals and Objectives

By the end of this rotation, the fellow is expected to:

  • Establish an appropriate and logical work up of suspected infections in this population
  • Understand the unique biological environment created within the musculoskeletal system by implantation of foreign device, and its impact on emergence and persistence of infection in this patient population
  • Understand the medical and surgical indications for management of orthopedic infections
  • Understand the role of infection control measures in this patient population (screening for carriage of organisms commonly associated with wound infection (staph aureus) organisms, pre-surgical antibiotic prophylaxis, etc)
  • Demonstrate appropriate inpatient and outpatient follow up care for this patient population
  • Communicate effectively with the orthopedic surgery service, both verbally and in the medical record

Mix of Clinical Topics

There are on average about 5-10 inpatient and 4-8 scheduled outpatient consults per week from the orthopedic service.  The fellow is expected to attend at least 1 outpatient ortho-ID clinic per week while undertaking this rotation.

Travel Clinicl (limited number of assigned clinics)

Each fellow will have 4 to 6 half-day Travel clinics during the second year of training.

Goals and Objectives

To gain facility in counseling and providing vaccines and medications for patients traveling to international destinations.

Virology Clinic COC

Over 600 patients are provided HIV care in the University of Iowa Hospitals & Clinics Virology Clinic.  An integrated multidisciplinary model is used to manage the complex needs that may be encountered.  Fellows gain experience by managing a panel of patients whom they follow during their fellowship.

Goals and Objectives:

  • Be comfortable with the evaluation of patients newly diagnosed with HIV/AIDS
  • Be comfortable initiating an ARV regimen, taking into account unique patient circumstances, and be familiar with adverse side-effects of the medications
  • Be familiar with risk factors, manifestations, diagnosis, treatment and prevention of opportunistic infections in HIV infected patients
  • Manage patients with HIV infection over years and provide preventive care for non-infectious complications of their infection.

Hospital Epidemiology

The goals of the year 1 rotation and year 2 elective are to give the fellows practical and scholarly training in Hospital Epidemiology/Infection Control.

During the Hospital Epidemiology rotation, fellows will participate in multiple activities of the Program of Infection Prevention at UIHC.  The goal is to understand the principles of surveillance and experience a programmatic approach to infection prevention, quality improvement and outbreak investigation. We anticipate this experience will ignite ideas for scholarly work/Quality Improvement.

Fellows complete one of the following: a) SHEA online infection control course (Primer on Healthcare Epidemiology, Infection Control & Antimicrobial Stewardship); or b) SHEA spring or fall meeting in infection prevention

Clinical Microbiology

During the second year, the Clinical Microbiology one-month rotation is not required, unless the fellow did not participate during the first year.

Goals and Objectives

By the end of this rotation, the fellow is expected to:

  • Understand and recommend various methods of appropriately collecting and transporting various specimen
  • Be competent in microscopic examination of specimen
  • Understand various staining and culturing techniques for a variety of bacterial, mycobacterial, fungal, and viral pathogens, and the principles and appropriateness of molecular diagnostic techniques
  • Be able to interpret susceptibility data, and limitations of testing
  • Understand mechanisms of antimicrobial resistance

Teaching Methods

Daily plate rounds with the Clinical Microbiology Lab: Complete bench rotations on checklist. Work with pathology resident on service to organize micro rounds with the ID consult Team I.

Microbiology lecture block, monthly micro conference

Additional Opportunities

Allergy/Immunology Rotation (elective)

Pediatric Infectious Disease Rotation (elective) 

ID Week

Second meeting of fellow’s choice (During Year 2 depending on track)

Conferences

  • Infectious Disease Grand Rounds (weekly): Two cases are presented by the fellows or staff as unknowns, discussed, and pertinent literature reviewed 
  • Core Curriculum Conference (weekly): didactic lectures on general and specialty ID topics over 2 year-cycle (see Curriculum for more details on topics)
  • Journal Club (monthly)
  • Research conference (weekly): progress on ongoing research activity is presented (ID Faculty and Fellows’ Conference)
  • Departmental Interdisciplinary Fellow's Curriculum (twice-monthly): presentations on common requirements of the fellowship programs including ethics, coding and billing, statistics, sleep deprivation, practice management, etc. [view schedule]
  • ID Week and second meeting of fellows’ choice
  • University of Iowa Update in Infectious Disease Regional CME Meeting (annually)
  • Various multi-disciplinary conferences, including Pathology Department Microbiology, Morbidity/Mortality, Internal Medicine Grand Rounds and Quality Improvement, etc.
  • ID Resident Curriculum Module Facilitation (monthly): 2nd year fellows
  • Clinical Micro tutorials twice a week for Team 1

Educational Opportunities

Training towards several degrees or participation in advanced training programs can occur during a 3rd and 4th year of fellowship. These include:

  1. Master’s of Public Health degree that is offered through the College of Public Health [more information]
  2. Master’s of Medical Education Degree (MME). The purpose of this program is develop a community of academic medical faculty with formal training in education who will create and sustain a culture of educational excellence within the College of Medicine, the university, and the medical education community at-large. [more information]
  3. Masters of Clinical Investigation is a 2-year interdisciplinary program which prepares post-doctoral fellows and junior faculty from the Colleges of Medicine, Nursing, Dentistry, and Pharmacy for careers in clinical research through a structured didactic curriculum in research methods and a mentored research experience. 
  4. Training as a clinical educator can also occur during the 2nd year of clinical fellowship through the Fellows as Clinician-Educators (FACE), a program developed within the Department of Medicine.
  5. Training in Healthcare Quality and Health Services Research can occur during respective 2-year Iowa City VA programs, after clinical fellowship (VA Quality Scholars or Health Services Research Fellowship). Clinical fellows are nominated per their request

Opportunities in Research/Scholarly Projects

Several funding opportunities are listed below for trainees who perform a third (and often a fourth) year of fellowship. There are visa limitations for several of the grants listed below.  Tuition support for graduate work has been available for fellows during their research years.

  1. Infectious Diseases Training Grant 
  2. Parasitism Training Grant
  3. Immunology Training Grant 
  4. VA Quality Scholars Program
  5. VA Health Services Research Felowship

The Division of Infectious Diseases offers a broad range of research opportunities, with faculty members conducting laboratory research in innate immunity, host-pathogen interactions, parasitology, and virology. There are also opportunities for projects in medical microbiology, antimicrobial stewardship, hospital epidemiology and infection prevention, healthcare delivery and quality improvement, computational epidemiology and with the Vaccine Trials Unit.  See below for more detailed information about specific programs or faculty members.

  • The Inflammation Program: An interdisciplinary multi-faculty basic science research program that studies innate immunity and host-pathogen interactions with studies related to Staph aureus, Leishmania, and other pathogens. [see the Inflammation Program website]. For faculty names see specific research interests.
  • Dr. Stapleton studies the interactions between flaviviruses and immune cells, GB virus C and co-infection and SARS-CoV-2.
  • Dr. Winokur leads the University of Iowa Vaccine Trials and Education Unit and the Institute for Clinical and Translational Science (ICTS).
  • Dr. Herwaldt is the PI for a CDC Infection Prevention Epi Center grant.  Care components include projects in antimicrobial stewardship and infection prevention. She is a PI for a second CDC grant in infection prevention and patient safety.
  • Dr. Wilson studies the pathogenesis, biology, immunology, and genetics of Leishmania. She has collaborative projects in Brazil with two adjunct Infectious Diseases faculty members (Drs. Jeronimo and Carvalho) and scholars in India. She coordinates international clinical experiences for trainees.
  • Dr. Meier studies basic mechanisms of CMV pathogenesis and latency, and he conducts HIV clinical research.
  • Dr. Tan studies polyomovirus infections in immunocompromised hosts; she conducts clinical therapeutic trials and vaccine trials.
  • Dr. Polgreen is the cofounder of the interdisciplinary Computational Epidemiology Program at the University of Iowa, which applies bioinformatics to infectious diseases. He is the director of the Emerging Infections Network (EIN), an infectious disease physicians' network for North America, sponsored by the CDC and IDSA, to surveille and gather information on various emerging and re-emerging infections.
  • Dr. Ohl is a member of the VA Comprehensive Access & Delivery Research & Evaluation Team (CADRE). He has developed innovative models to provide HIV care to veterans and Hep C care in rural settings via telehealth. He studies healthcare quality and delivery. He directs a program for TelePrEP across the state and is trained in Addiction Medicine.
  • Dr. Ince, director of the Transplant Infectious Disease program, also is the physician champion of the UIHC Antimicrobial Stewardship Program (AMS) and is active in the IDSA AMS curriculum and clinical trials for solid organ transplant.
  • Dr. Goto is a member of CADRE at the VA. He studies ID-related healthcare outcomes and healthcare quality using VA databases. He is trained in bio-informatics.
  • Dr. Livorsi researches healthcare quality and delivery, with a focus on antimicrobial stewardship.  He is a member of the VA CADRE group and a Medical Co-Director of the VA AMS team.
  • Dr. Sekar specializes in Ortho ID at UIHC and performs MSK infection-related research at the VA and is involved in quality improvement projects.
  • Dr. Suzuki conducts research in healthcare delivery and antimicrobial stewardship.  He is the Hospital Epidemiologist at the VA.
  • Dr. Carvour has an interest in clinical Ortho ID, Ortho ID clinical research and research in health equity for patients with ID diagnoses. She also studies the disparate impact of COVID in the community and the COVID/diabetes syndemic.
  • Dr. Prasidthrathsint oversees Clinical Micro projects.
  • Dr. Kobayashi is the associate hospital epidemiologist, oversees quality improvement projects and conducts research in hospital epidemiology.
  • Dr. Barker is involved in medical education initiatives.
  • Dr. Non oversees transplant ID quality improvement projects.
  • Dr. Appenheimer and Dr. Kaewpoowat are involved in fellow educational initiatives.
  • Dr. Kaewpoowat is involved in a state telehealth program to provide ID care to patients with substance use disorders.

Scholarly Activity during ID Fellowship

Year One

Two to three months of the first year are not assigned to clinical rotations. Part of this time is vacation. During the remaining time, the fellow is expected to meet with faculty members within or outside the division to discuss possible scholarly projects. Under faculty members’ mentorship, we anticipate that by the end of year 1 a project has been selected.

Scholarly work can include ID-related quality improvement projects, Antimicrobial Stewardship projects or research initiatives, Hospital Epi research, or clinical reviews/case series, bench research or clinical research.

Year Two                

Three to four months of the year are dedicated to consult work.  Thus, the second year of fellowship allows for significant time to develop and execute a scholarly project. A mentor will guide the project, and a research committee or co-mentor selected from other faculty members will provide additional guidance as needed. Results of the fellows’ work will be presented during the ID Faculty and Fellows’ Conference toward the end of year 2.

Year Three/Four

A third (and often a fourth) year of fellowship is available for those who plan a career in academics and are engaged in a fruitful research project during clinical fellowship (see Fellowship Tracks). Building on productive scholarly work initiated during Year 2, the majority of Year 3 and 4 are dedicated to research/scholarly work and possibly course work

Select publication by Infectious Disease fellows:

Joseph Tholany (graduating 2022)

Tholany, J, Kobayashi, T, Marra, AR, Schweizer, ML, Samuelson, RJ, Suzuki, H. Impact of infectious diseases consultation on the outcome of patients with enteroccoal bacteremia: a systemic literature review and meta-analysis. OFJD, ofac200, epublished April 12, 2022;  https://doi.org/10.1093/ofid/ofac200

Matthew Smith (graduating 2022)

Smith M, Kobayashi T, Sekar P. Antibody testing to distinguish between histoplasmosis and blastomycosis. BMJ Case Rep. 2021 May 31;14(5):e243587. doi: 10.1136/bcr-2021-243587.

Livorsi, DJ, Nair, R, Dysangco, A, Aylward, A, Alexander, B, Smith, MW, Kouba, S, Perencevich, EN. Using audit-and-feedback to improve antimicrobial-prescribing in Emergency Departments: a multicenter quasi-experimental study in the Veterans Health Administration. Open Forum Infectious Diseases, ofab186, April 14, 2021.

Fernando Casado Castillo (graduated 2021)

Casado-Castillo F, Kobayashi T, Sekar P, Streit J, Molano De Pena I. Prosthetic hip infection due to Salmonella enterica serovar Enteritidis. IDCases. 2021 May 23;25:e01170. doi: 10.1016/j.idcr.2021.e01170.

Kobayashi T, Trannel A, Holley SA, Alsuhaibani M, Abosi OJ, Jenn KE, Meacham H, Sheeler LL, Etienne W, Dains A, Casado F, Kukla ME, Ward E, Ford B, Edmond MB, Wellington M, Diekema DJ, Salinas JL. COVID-19 Serial Testing among Hospitalized Patients in a Midwest Tertiary Medical Center, July-September 2020. Clin Infect Dis. 2020 Oct 26:ciaa1630. doi: 10.1093/cid/ciaa1630. Online ahead of print.PMID: 33103196

Edin Pujagic (graduated 2021)

Kobayashi, T, Bogdanic, F, Pujagic, E, Goto, M. Isolated Splenic Abscess due to Salmonella Berta in a Healthy Adult. BMJ Case Rep. 2020 Apr 7;13(4). pii: e235318. doi: 10.1136/bcr-2020-235318

Htay Phyu (graduated 2020)

Phyu, H, Edmond, MB, Kobayashi, T. Metronidazole-Induced Encephalopathy ID Cases. 2019 Sep 7; 18:e00639 doi: 10.1016/j.idcr.2019.e00639. eCollection 2019. PMID 31692663

Phyu, H, Kobayashi, T., Rastogi, P, Cho, C. Vancomycin-induced linear Immunogloblulin A bullous dermatosis. BMJ Case Reports, Dec 2019, 12(12) e233281: DOI: 10.1136/bcr-2019-233281 PMID 31822537

Phyu H, Kobayashi T, Ford, B, Molano, I. Splenic abscess as a rare presentation of blastomycosis. BMJ Case Rep. 2020 Feb 13; 13(2). Pii: e234062. Doi: 10.1136/bcr-2019-234062 PMID 32060116

Takaaki Kobayashi (graduated 2020)

Kobayashi T, Trannel A, Holley SA, Alsuhaibani M, Abosi OJ, Jenn KE, Meacham H, Sheeler LL, Etienne W, Dains A, Casado F, Kukla ME, Ward E, Ford B, Edmond MB, Wellington M, Diekema DJ, Salinas JL. COVID-19 Serial Testing among Hospitalized Patients in a Midwest Tertiary Medical Center, July-September 2020. Clin Infect Dis. 2020 Oct 26:ciaa1630. doi: 10.1093/cid/ciaa1630. Online ahead of print.PMID: 33103196

Kobayashi T, Amram AL, Gehrs K, Diekema D, Barker J. A 52-Year-Old Man With Uveitis and Altered Mental Status. Clin Infect Dis. 2021 Mar 1;72(5):873-875. doi: 10.1093/cid/ciaa051.PMID: 33667312

Kobayashi T, Salinas JL, Ten Eyck P, Chen B, Ando T, Inagaki K, Alsuhaibani M, Auwaerter PG, Molano I, Diekema DJ. Palliative care consultation in patients with Staphylococcus aureus bacteremia. Palliat Med. 2021 Apr;35(4):785-792. doi: 10.1177/0269216321999574. Epub 2021 Mar 24.PMID: 33757367

Kobayashi T, Marra AR, Schweizer ML, Ten Eyck P, Wu C, Alzunitan M, Salinas JL, Siegel M, Farmakiotis D, Auwaerter PG, Healy HS, Diekema DJ. Impact of Infectious Disease Consultation in Patients With Candidemia: A Retrospective Study, Systematic Literature Review, and Meta-analysis. Open Forum Infect Dis. 2020 Aug 3;7(9):ofaa270. doi: 10.1093/ofid/ofaa270. eCollection 2020 Sep.PMID: 32904995

Kobayashi T, Beck B, Miller A, Polgreen P, O'Shea AMJ, Ohl ME. Positive Predictive Values of 2 Algorithms for Identifying Patients with Intravenous Drug Use-Associated Endocarditis Using Administrative Data. Open Forum Infect Dis. 2020 Jun 1;7(6):ofaa201. doi: 10.1093/ofid/ofaa201. eCollection 2020 Jun.PMID: 32607386

Kobayashi T, Jenn KE, Bowdler N, Malloy R, Holley S, Izakovic T, Kukla ME, Abosi O, Dains A, Meacham H, Diekema DJ, Edmond MB, Salinas JL. Reduction in abdominal hysterectomy surgical site infection rates after the addition of anaerobic antimicrobial prophylaxis. Infect Control Hosp Epidemiol. 2020 Dec;41(12):1469-1471. doi: 10.1017/ice.2020.386. Epub 2020 Aug 28.PMID: 32856576

Kobayashi T, Meacham H, Alsuhaibani M, Holley S, Marra AR, Edmond MB, Diekema DJ, Hartley PG, Salinas JL. Occupational tuberculosis exposures and conversion rates can guide deimplementation of annual tuberculosis skin test screening. Infect Control Hosp Epidemiol. 2021 Jan;42(1):123-124. doi: 10.1017/ice.2020.205. Epub 2020 Jun 2.PMID: 32484119

Kobayashi T, Clore GS, Kukla ME, Alzunitan M, Kritzman J, Abosi O, Puig-Asensio M, Marra AR, Diekema DJ, Edmond MB, Salinas JL. Insertion site inflammation was associated with central-line-associated bloodstream infections at a tertiary-care center, 2015-2018. Infect Control Hosp Epidemiol. 2021 Mar;42(3):348-350. doi: 10.1017/ice.2020.445. Epub 2020 Oct 9.PMID: 33032671

Kobayashi T, Ford B, Fujita N, Appenheimer AB. Ocular Actinomycosis Mimicking Meningioma. Open Forum Infect Dis. 2020 May 19;7(6):ofaa170. doi: 10.1093/ofid/ofaa170. eCollection 2020 Jun.PMID: 32529000

Kobayashi T, Lawler E, Samra H, Ford B, Sekar P. Prosthetic Finger Joint Infection Due to Aspergillus terreus. Open Forum Infect Dis. 2020 Dec 13;8(1):ofaa614. doi: 10.1093/ofid/ofaa614. eCollection 2021 Jan.PMID: 33511236

Kobayashi T, Ando T, Streit J, Sekar P. Current Evidence on Oral Antibiotics for Infective Endocarditis: A Narrative Review. Cardiol Ther. 2019 Dec;8(2):167-177. doi: 10.1007/s40119-019-00148-4. Epub 2019 Sep 18.PMID: 31535282

Sammantha Kouba (graduated 2020)

Kouba SJ, Kobayashi T, Blount RJ, Herwaldt L. Atrial flutter as a rare manifestation of leptospirosis. BMJ Case Rep. 2020 Aug 26:13(8)e237693 PMID 32847893

Kouba S, Kobayashi T, Meier J, Sekar, P. Osseous blastomycosis mimicking malignancy. BMJ Case Rep. 2020 Aug 25;13(8):e237688 PMID 32843470

Livorsi, DJ, Nair, R, Dysangco, A, Aylward, A, Alexander, B, Smith, MW, Kouba, S, Perencevich, EN. Using audit-and-feedback to improve antimicrobial-prescribing in Emergency Departments: a multicenter quasi-experimental study in the Veterans Health Administration. Open Forum

Hiroyuki Suzuki (graduated 2019)

Suzuki H, Perencevich EN, Livorsi DJ, Alexander B, Beck BF, Richardson KK, Goto M. Attributable mortality due to fluoroquinolone and extended-spectrum cephalosporin resistance in hospital-onset Escherichia coli and Klebsiella spp bacteremia: A matched cohort study in 129 Veterans Health Administration medical centers. Infect Control Hosp Epidemiol. 2019 Aug;40(8):928-931.

Suzuki H, Perencevich EN, Alexander B, Beck BF, Goto M, Lund BC, Nair R, and Livorsi DJ. Inpatient Fluoroquinolone Stewardship Improves the Quantity and Quality of Fluoroquinolone-prescribing at Hospital Discharge: A Retrospective Analysis among 122 Veterans Health Administration Hospitals. Clin Infect Dis. 2020 Aug 22;71(5):1232-1239.

Suzuki H, Perencevich EN, Nair R, Livorsi DJ, Goto M. Excess Length of Acute Inpatient Stay Attributable to Acquisition of Hospital-Onset Gram-Negative Bloodstream Infection with and without Antibiotic Resistance: A Multistate Model Analysis. Antibiotics 2020, 9(2), 96

Suzuki H, Clore G, Perencevich EN, Hockett-Sherlock S, Goto M, Nair R, Branch-Elliman W, Richardson K, Gupta K, Beck BF, Alexander B, Balkenende E, Schweizer ML. Development of a Fully Automated Surgical Site Infection Detection Algorithm for Use in Cardiac and Orthopedic Surgery Research. Infect Control Hosp Epidemiol. 2021 Feb 23;1-6.

Suzuki H, Perencevich EN, Goto M, Nair R, Puig-Asensio M, Ernst E, Livorsi DJ. A Comprehensive Assessment of Carbapenem Use across 90 Veterans Health Administration Hospitals with Defined Stewardship Strategies for Carbapenems. J Antimicrob Chemother. 2021 Feb 1;dkab008.

Christine Cho (graduated 2017)

Cho C, Teghanemt A, Apicella MA, Nauseef WM. Modulation of phagocytosis-induced cell death of human neutrophils by Neisseria gonorrhoeae. J Leukoc Biol. 2020 September 25. doi: 10.1002/JLB.4MA0820-649R.

Kobayashi T, Swick BL, Cho C. Clinical image: chronic skin ulcers in a patient with rheumatoid arthritis on immunosuppressant therapy. Clin Rheumatol. 2020 Jun 26. doi:10.1007/s10067-020-05251-9.

Phyu H, Kobayashi T, Cho C, Rastogi P. Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis. BMJ Case Reports. 2019;12:e233281.

Kobayashi T, Cho C. Mediastinal granuloma due to histoplasmosis in a patient on infliximab. Cleveland Clinic Journal of Medicine. 2019;86(9):579-581.

Benjamin Avner (graduated 2017)

Amjadi MF, Avner BS, Greenlee-Wacker MC, Horswill AR, Nauseef WM (2021). Neutrophil-derived extracellular vesicles modulate the phenotype of naïve human neutrophils. J Leukoc Biol (published online ahead of print) PMID 33682200

Alpheus (Benjamin) Appenheimer (graduated 2016)

Appenheimer AB, Bokhour B, McInnes DK, Richardson KK, Thurman AL, Beck BF, Vaughan-Sarrazin M, Asch SM, Midboe AM, Taylor T, Dvorin K, Gifford AL, Ohl ME. Should HIV Specialty Clinics Treat Patients with Hypertension or Refer to Primary Care? An Analysis of Treatment Outcomes. Open Forum Infectious Diseases. 2017 Feb 3;4(1):ofx005.

Julian KG, Crook T, Curley E, Appenheimer AB, Paules CI, Hasse B, Diekema DJ, Daley CL, de Sanctis J, Hellinger WC, Levin A, McSherry G, Freer C, Whitener CJ. Long-term follow-up of post-cardiac surgery Mycobacterium chimaera infections: A 5-center case series. J Infect. 2020 Feb;80(2):197-203

Kobayashi T, Ford, B, Fujita, N, Appenheimer, AB. Ocular actinomycosis mimicking meningioma, Open Forum Infectious Diseases. 2020 June; 7 (6): ofaa170

Thulasi P, Saeed HN, Rapuano CJ, Hou JH, Appenheimer AB, Chodosh J, Kang JJ, Morrill AM, Vyas N, Zegans ME, Zuckerman R, Tu EY. Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis. Am J Ophthalmol. 2020 Oct 10;223:75-82. doi: 10.1016/j.ajo.2020.09.048. Epub ahead of print. PMID: 33045218

Kunatum Prasidthrathsint (graduated 2015)

Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell IV J, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt, L, Raabe, V, Cannavino, CR, Green Hines A, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le B-M, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ. Severe Influenza in 33 US Hospitals, 2013–2014: Complications and Risk Factors for Death in 507 Patients. Infection Control & Hospital Epidemiology, July 2015;00(0):1-10

Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ. Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients. Infect Control Hosp Epidemiol. 2015 Nov; 36(11):1251-60

Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J 4th, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani FJ, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ. Bacterial and viral co-infections complicating severe influenza: incidence and impact among 507 U.S. Patients 2013-2014. J Clin Virol. 2016 Jul;80:12-9

Prasidthrathsint K, Voigt M, Streit JS. Association of Q Fever with Autoimmune Hepatitis. J of Autoimmune Disorders, 1:1, 2015

Prasidthrathsint, K., Lewis, J. & Couturier, M. R. (2017). The Brief Case: Angiostrongylus cantonensis Eosinophilic Meningitis in a Returned Traveler. (Vols. 55). (10), pp. 2880-2883. Journal of clinical microbiology. PMID: 28947508. 2017

Prasidthrathsint, K., Fisher, M. A. (2017). Antimicrobial Susceptibility Patterns among a Large, Nationwide Cohort of Abiotrophia and Granulicatella Clinical Isolates. Journal of clinical microbiology, 55(4), 1025-1031. PMID: 28077699. 2017

Prasidthrathsint K, Stapleton JT. Laboratory Diagnosis and Monitoring of Viral Hepatitis. Gastroenterol Clin North Am. 2019 Jun;48(2):259-279. PMID 31046974

Michihiko Goto (graduated 2014)

All citations can be reviewed at: https://www.ncbi.nlm.nih.gov/myncbi/michihiko.goto.1/bibliography/public/

Goto M, Harris AD, Perencevich EN. Contact Precautions and Methicillin-Resistant Staphylococcus aureus-Modeling Our Way to Safety. JAMA Netw Open. 2021 Mar 1;4(3):e211574. doi: 10.1001/jamanetworkopen.2021.1574. PubMed PMID: 33720366.

Goto M, Ueckert N, Meiches RK, Perencevich EN. Successful multimodal measures preventing coronavirus disease 2019 (COVID-19) outbreaks without universal frequent testing within long-term care units in the Midwestern Veterans' Health Care Network. Infect Control Hosp Epidemiol. 2021 Jan 11;:1-3. doi: 10.1017/ice.2020.1419. [Epub ahead of print] PubMed PMID: 33427153; PubMed Central PMCID: PMC7853753.

Feller J, Lund BC, Perencevich EN, Alexander B, Heintz B, Beck B, Nair R, Goto M, Livorsi DJ. Post-discharge oral antimicrobial use among hospitalized patients across an integrated national healthcare network. Clin Microbiol Infect. 2020 Mar;26(3):327-332. doi: 10.1016/j.cmi.2019.09.016. Epub 2019 Oct 7. PubMed PMID: 31600582.

Suzuki H, Perencevich EN, Nair R, Livorsi DJ, Goto M. Excess Length of Acute Inpatient Stay Attributable to Acquisition of Hospital-Onset Gram-Negative Bloodstream Infection with and without Antibiotic Resistance: A Multistate Model Analysis. Antibiotics (Basel). 2020 Feb 23;9(2). doi: 10.3390/antibiotics9020096. PubMed PMID: 32102195; PubMed Central PMCID: PMC7168210.

Goto M, Jones MP, Schweizer ML, Livorsi DJ, Perencevich EN, Richardson K, Beck BF, Alexander B, Ohl ME. Association of Infectious Diseases Consultation With Long-term Postdischarge Outcomes Among Patients With Staphylococcus aureus Bacteremia. JAMA Netw Open. 2020 Feb 5;3(2):e1921048. doi: 10.1001/jamanetworkopen.2019.21048. PubMed PMID: 32049296.

Eiyu Matsumoto (graduated 2013)

Suzuki, H, Carlson JR, Matsumoto E. Treatment of Enterococcus faecalis infective endocarditis with penicillin G plus ceftriaxone. Infect Dis (Lond). 2020 Feb: 52(2): 135-138, PMID 31566044

Matsumoto, S., Matsumoto, E. A Case Report “A 20-Month-Old Girl With Fever, Seizures, Hemiparesis, and Brain Lesions Requiring a Diagnostic Brain Biopsy.” Seminars in Pediatric Neurology (available online, https://doi.org/10.1016/j.spen.2017.03.012)

Matsumoto, E., Carlson, J., Mini-Review for Clinicians, UTI Case Study 1”. Consultant. 2017;57(8):464-467. (last accessed on 12/12/2017.)

Matsumoto, E., Carlson, J., Xu, A., Mini-Review for Clinicians, UTI Case Study 2. Consultant. 2017;57(9):526-529. (last accessed on 12/12/2017)

Matsumoto, E., Carlson, J., Xu, A., Mini-Review, Recurrent C. difficile Infection, Case-Based-Approach. Consultant. 2017;57(10):583-587. (Last accessed on 12/12/2017.)

Matsumoto, E., Miller, S., Dika, M., Ferguson, N., Holte, A., Carlson, J., Photo Quiz 360, A thumb lesion in a farmer; Orf (Ecthyma Contagiosum). Consultant. 2017;57(10):609. (Last accessed on 12/12/2017.)

Matsumoto, E., Carlson, J., How Would You Triage This Patient’s Low Back Pain? (last accessed in 3/2019)

Streit JA, Matsumoto E. African Trypanosomiasis. N Engl J Med. 2016;375(24):2380. PMID: 27974038.

Major Areas of Scholarly Work

Hospital Epidemiology/Epidemiology of Infections/Healthcare Quality

  • Prevention of healthcare associated infections (Dr. Loreen Herwaldt, Dr. Karen Brust, Dr. Takaaki Kobayashi) or other infection prevention topics
  • Antimicrobial stewardship (Drs. Livorsi, Suzuki and Ince)
  • Healthcare Quality and Delivery (Drs. Goto, Ohl, Livorsi, Suzuki)
  • Computational Epidemiology Program (Drs. Polgreen and Miller)
  • Delayed ID diagnoses, C. difficile epidemiology (Drs. Polgreen and Miller)

Host defense/Inflammation (Faculty members of the Inflammation Program)

  • Mediators of inflammation in metabolic disorders
  • Host-pathogen interactions (Staph aureus, Leishmania, Flavivirus, Polyomavirus)
  • Innate and cell-mediated immunity
  • Phagocyte biology, signal transduction, molecular recognition, antimicrobial peptides
  • T-regulatory cell development
  • Projects with Microbiology/Immunology Department faculty

Global Health and Parasitology Research

  • Basic biology and genetics of Leishmania ; immune response to Leishmania
  • Epidemiology of M. leprae infection
  • Short-term clinical Leishmania research projects in India or Brazil
  • Clinical experiences in Brazil or India
  • Collaborators in India: Common causes of febrile illness and encephalitis in Northern India

Clinical Research/Translational Research

  • Vaccine Trials
  • Ortho ID
  • Transplant ID
  • Equity in delivery of ID care
  • Polyomaviruses
  • Antiviral clinical trials

Medical Microbiology

  • Projects in clinical micro (Drs. Ford and Prasidthrathsint)

Emerging Infections Network

  • National ID provider survey projects available with Drs. Polgreen and Herwaldt

Clinical Reviews or Case Series/Case Reports

Medical Education

Interdisciplinary Fellowship Conference

Below is an example of the Department of Internal Medicine Common Curriculum Schedule. It is shared between Fellows from all divisions of the Department.

PDF icon2022-23 Fellows Conference Master Schedule.pdf

Fellows as Clinician Educators (FACE)

The Fellows as Clinician Educators (FACE) Program is designed to introduce future clinician-educators to a set of skills which may be of use in their career. The program presents concepts of educational design and research, lecture development, evaluation, observation and feedback. At the conclusion of the program, FACE participants are required to develop a teaching portfolio.

Learn more about FACE 

Why Infectious Disease at Iowa?

University of Iowa Hospitals & Clinics offers the best traditions in academic excellence, collaborative patient care and innovative research, with the added benefits of Iowa City's affordable living, healthy lifestyle, and appreciation for the arts.  Highlights of training at Iowa include:

  • Outstanding ID clinical training in a dynamic quaternary care medical center. We are Iowa’s only academic medical center. Our clinical catchment area is large and includes a significant number of foreign-borne people who work or study at the university or are involved in agriculture. The remarkable variety of infectious diseases we encounter demands that we remain active learners and educators.
  • State-of-the-art Microbiology Lab with longitudinal medical microbiology training with the possibility to pursue Clinical Microbiology Fellowship
  • Individualized, customizable fellowship tracks:
    • Clinician-Educator
    • Health Care Services and Healthcare Quality
    • Physician Investigator
  • H-1B and J-1 visa sponsorship
  • Opportunities for mentored scholarly work
  • Enjoy readily-available cultural amenities, diversity, and sports programs of an award-winning Big Ten University city
  • 100% board pass rate over >10 years
  • Busy transplant program
  • Ryan White -funded HIV multidisciplinary clinic
  • Opportunities for global health experiences
  • Opportunities for research fellowships after clinical fellowship

UI Hospitals & Clinics and the Carver College of Medicine:

  • America’s Best Large Employers; #1 in Iowa for healthcare, #6 overall for Iowa; #47 of 500 nationwide for Diversity (Forbes)
  • Best Graduate Schools, U.S. News and World Report
  • America’s Best Hospitals List, U.S. News and World Report
  • America’s Best Children’s Hospitals List, U.S. News and World Report
  • Magnet Hospital Designation
  • #17 Internal Medicine Residency

Iowa City, a top place to live:

  • Iowa City/Coralville, home to the University of Iowa, has a population of approximately 100,000 people, plus 30,000 students
  • Nearby Cedar Rapids/Marion has a population of approximately 170,000
  • #3 Best Places to Live List, Outside Magazine
  • #2 Most Fitness Friendly Places for 2020 (Smartasset); great outdoor activities nearby
  • #3 of 10 Best Places to Get a Fresh Start 2019 (Livability)
  • #10 of 25 Safest College Campuses
  • #13 The 50 Happiest Cities (USA Today)
  • World City of Literature, UNESCO; Home of the internationally renowned Iowa Writer’s Workshop

How to Apply

Thank you for your interest in infectious diseases, an incredibly rich, diverse, and rewarding specialty. As is evidenced by the ongoing COVID-19 pandemic, the bounds of our specialty know no limits, spanning pathogenesis, clinical care, disaster planning, infection control and prevention, immunology and vaccine development, public health, social determinants of health, diagnostic testing, and communication skills. While the task is daunting, we will overcome this pandemic, in large part thanks to the tireless efforts of infectious diseases experts and advocates everywhere.

IDSA, the ID Training Program Directors’ Committee, and all ID program directors understand that the fellowship application season falls during this complex and chaotic time. We also understand that some anticipated ID clinical elective rotations may not be undertaken, that anticipated research projects may not be completed, and that previously envisioned letters of recommendation may not materialize. We assure you that we will review all applications mindful of these realities, and we will not hold schedule changes imposed by COVID-19 against any applicant.

We strongly encourage anyone who is considering applying for ID fellowship training to apply, and not to withhold your application because of these concerns. We welcome your interest in infectious diseases and our program, and we look forward to meeting many of you on the interview trail this year, whether in person or remotely

 

Applications are only accepted through the Electronic Residency Application System (ERAS).

US residents should contact their Dean's Office or ERAS at https://students-residents.aamc.org/training-residency-fellowship/applying-fellowships-eras/.

International residents should contact the ECFMG at http://www.ecfmg.org/eras/index.html. Sponsorship of J-1 visas is preferred (on occasion H-1b).

An ECFMG certificate must accompany the ERAS application.

A background of research experience is not essential. However, we would encourage applicants who have a strong interest in pursuing an academic Infectious Diseases career. Our research programs range from Clinical Infectious Diseases (antibiotic stewardship, transplantation), Epidemiology (infection control, emerging infections network), Translational Research (vaccines, clinical trials, antibiotic/antifungal resistance), and Basic Research (virology, parasitology, bacteriology, and innate and adaptive immunity).

A complete ERAS application includes:

  • Curriculum vitae
  • Statement of the applicant's long-term career goal and field of interest
  • Dean's letter
  • Three letters of support
  • Copies of ECFMG scores for Steps I, II, and III (if completed)
  • Notarized copies of applicant's transcripts for USMLE Steps 1, 2, and 3
  • Medical school transcript
  • An unmounted recent photograph of applicant must accompany application or be provided at time of interview.

All applicants must also register with the National Resident Matching Program (Phone: 202-828-0566).
The NRMP numbers for our program is 1203146F0.

The deadline for applications is September 30.
Selected candidates will be invited to interview.

Application Deadline

The deadline for applications is September 30.

Board Certification

Medical specialty certification in the United States is a voluntary process which serves multiple purposes for the trainee and the public.

Certification is

  • one mission of the training program to produce trainees who meet board eligibility criteria;
  • distinguishes a physician as someone with a distinct level of expertise;
  • provides more opportunities when applying for employment;
  • presents resources and tools by the ABMS; 
  • a commitment to life-long improvement for providing the best patient care; and
  • elevates physicians into the ranks of doctors committed to the highest standards of healthcare.

For more information visit the American Board of Internal Medicine for specifics on board certification requirements.

Eligibility Criteria

Qualifications for candidates include (1) an MD degree (or equivalent), (2) completion or expected completion of three years of residency training in Internal Medicine, with Board Eligibility or Certification by the American Board of Internal Medicine, by the initiation of Infectious Diseases Fellowship training

Interview Information

At the interview, perspective candidates will receive an overview of the program and tour of the facilities. They will also meet individually with key faculty members that may include any or all of the following: the program director, other Infectious Diseases faculty, and the department chair.

Our People

Program Leadership

 

Judy A. Streit, MD
Director, Infectious Diseases Fellowship Program
Clinical Professor of Internal Medicine

Phone: 319-356-7226
Email: judy-streit@uiowa.edu

 

A. Benjamin Appenheimer, MD
Assistant Director, Infectious Diseases Fellowship Program
Clinical Associate Professor of Internal Medicine

Phone: 319-356-8708
email: alpheus-appenheimer@uiowa.edu

 

Ilonka Molano, MD
Assistant Director, Infectious Diseases Fellowship Program
Clinical Associate Professor of Internal Medicine

Phone: 319-384-6186
email: ilonka-molano@uiowa.edu

Current Faculty

The Department of Internal Medicine has a faculty of nearly 300 professionals whose clinical, teaching, and research expertise spans the entire discipline of medicine.

Infectious Diseases Division Faculty

Department Faculty (alphabetical listing)

Other Faculty with Infectious Diseases interest

Perencevich, Eli N., MD, MS (General Internal Medicine)
Ford, Bradley, MD, PhD (Pathology)

Current Fellows

 

Nirmal Muthukumarasamy, MBBS (F1)
Medical School: Jawaharlal Institute
Residency: Western Michigan University

Mike Olthoff

 

Mike Olthoff, MD (F2)
Medical School: University of Iowa
Residency: University of Iowa

 

Abhishek Pandya, MD (F1)
Medical School: St. James School of Medicine, St Vincent and the Grenadines
Residency: Loyola University

Andrew Simms

 

Andrew Simms, MD (F1)
Medical School: University of Nebraska
Residency: University of Iowa

 

Thomas Wright, MD (F1)
Medical School: Indiana University
Residency: Summa Health System

 

VA Research Fellows (adjunct appointments)

 

Matt Smith, MD
VA Health Services Research Fellow
Medical School: University of Nebraska
Residency: University of Iowa

 

Joseph Tholany, MD
VA Quality Scholar
Medical School: St. George's University School of Medicine
Residency: University of Pittsburgh

Research Groups

Host Defense Group

Botond Bánfi, MD, PhD
Associate Professor of Anatomy and Cell Biology		 Polly Ferguson, MD
Professor of Pediatrics		 Prajwal Gurung, PhD
Associate Professor of Medicine (Infectious Diseases)
John T. Harty, PhD*
Professor of Microbiology		 Priya Issuree, PhD
Assistant Professor of Medicine (Infectious Diseases)		 Julia Klesney-Tait, MD, PhD
Associate Professor of Medicine (Pulmonary)
Kevin Legge, PhD
Professor of Pathology		 Thorsten Maretzky, PhD
Assistant Professor of Medicine (Infectious Diseases)		 Paul McCray, MD
Professor of Pediatrics
Craig Morita, MD, PhD
Professor of Medicine (Rheumatology)		 William M. Nauseef, MD*
Emeritus Professor of Medicine (Infectious Diseases)		 Elizabeth Newell, MD
Assistant Professor of Pediatrics
Stanley Perlman, MD, PhD*
Professor of Microbology		 Mary E. Wilson, MD
Professor of Medicine and Microbiology		  

Molecular Pathogenesis Group

Viral Pathogenesis Subgroup

Zuhair Ballas, MD
Professor of Medicine (Allergy)		 Gail Bishop, PhD
Professor of Medicine and Microbiology		 Charles Grose, MD
Professor of Pediatrics
Hillel Haim, PhD
Assistant Professor of Microbiology		 Aloysius J. Klingelhutz, PhD
Professor of Microbiology		 Wendy Maury, PhD
Professor of Microbiology
Jeffery Meier, MD
Professor of Medicine (Infectious Diseases)		 Stanley Perlman, MD, PhD
Professor of Microbiology		 David Price, PhD
Professor, Department of Biochemistry
Richard J. Roller, PhD
Professor of Microbiology		 Jack Stapleton, MD
Professor of Medicine (Infectious Diseases)		 C. Martin Stoltzfus, PhD
Professor of Medicine (Microbiology)
Joseph Zabner, MD
Professor of Medicine (Pulmonary)		    

Bacterial Pathogenesis Subgroup

John T. Harty, PhD
Professor of Medicine (Microbiology)		 Li Wu, PhD
Professor and Chair, Department of Microbiology		 Paul McCray, MD*
Professor of Pediatrics
Craig Morita, MD, PhD*
Professor of Medicine (Rheumatology)		 William M. Nauseef, MD*
Emeritus Professor of Medicine (Infectious Diseases)		 Patricia L. Winokur, MD
Professor of Medicine (Infectious Diseases)

Associate Members

    
Steven Clegg, PhD
Professor of Medicine (Microbiology)		 Daniel J. Diekema, MD, MS
Associate Professor of Clinical Medicine (Infectious Diseases)		 Timothy L. Yahr, PhD
Associate Professor of Microbiology
Bradley Jones, PhD
Professor of Microbiology		    

Eukaryotic Pathogenesis Subgroup

Noah Butler, PhD
Associate Professor of Microbiology and Immunology		 John T. Harty, PhD
Professor of Microbiology 		 Louis V. Kirchhoff, MD, MPH
Professor of Medicine (Infectious Diseases)
W. Scott Moye-Rowley, PhD
Professor of Physiology & Biophysics		 Mary E. Wilson, MD
Professor of Medicine (Infectious Diseases)		  

Hospital epidemiology/Healthcare Research

Karen Brust, MD, Clinical Associate Professor of Medicine (Infectious Diseases) Michihiko Goto, MD, MSCI, FACP
Associate Professor of Medicine (Infectious Diseases)		 Loreen Herwaldt, MD
Professor of Medicine (Infectious Disease)
Takaaki Kobayashi, MD, MPH Clinical Assistant Professor of Medicine (Infectious Diseases) Daniel Livorsi, MD, MSC
Associate Professor of Medicine (Infectious Diseases)		 Michael Ohl, MD, MPH
Professor of Medicine (Infectious Disease)
Eli Perencevich, MD, MS
Professor of Medicine and Epidemiology		 Philip Polgreen, MD, MPH
Professor of Medicine (Infectious Disease)		  

Clinical and Vaccine Research (ID Division)

Patricia Winokur, MD
Professor of Medicine (Infectious Disesse)		 Jack Stapleton, MD
Professor of Medicine (Infectious Disease) 		 Jeffery Meier, MD
Professor of Medicine (Infectious Disease)

Clinical Microbiology Research

Bradley Ford, MD, PhD
Clinical Assistant Professor of Pathology		 J. Stacey Klutts, MD, PhD
Assistant Professor of Pathology		 Kunatum (Jin) Prasidthrathsint, MD Clinical Assistant Professor of Medicine (Infectious Diseases)
 

Chair, Department of Internal Medicine

Isabella Grumbach, MD, PhD
Interim Chair and DEO, Department of Internal Medicine
Kate Daum Endowed Professor
Professor of Medicine – Cardiovascular Medicine
Professor of Radiation Oncology